Study of Depression, Peptides, and Steroids in Cushing's Syndrome
2 other identifiers
observational
8
1 country
1
Brief Summary
OBJECTIVES: I. Study the relationship between dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and disorders of mood, vegetative function, and cognition in patients with Cushing's disease. II. Identify subgroups of patients with Cushing's disease who differ in the presence and severity of the depressive syndrome, and uncover HPA axis dysregulation differences among them using corticotropin-releasing hormone, metyrapone, and dexamethasone challenge testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 1994
CompletedFirst Submitted
Initial submission to the registry
October 18, 1999
CompletedFirst Posted
Study publicly available on registry
October 19, 1999
CompletedJune 24, 2005
December 1, 2003
October 18, 1999
June 23, 2005
Conditions
Keywords
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University of Michigan Health Systems
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Monica N. Starkman
University of Michigan
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
October 18, 1999
First Posted
October 19, 1999
Study Start
July 1, 1994
Last Updated
June 24, 2005
Record last verified: 2003-12